Safety, reactogenicity, and immunogenicity of a 12-valent pneumococcal non-typeable


Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
04 05 2021
Historique:
pubmed: 12 11 2020
medline: 6 7 2021
entrez: 11 11 2020
Statut: ppublish

Résumé

As a stepping stone toward evaluation in infants, the safety and immunogenicity of an investigational 12-valent pneumococcal non-typeable

Identifiants

pubmed: 33175600
doi: 10.1080/21645515.2020.1810493
pmc: PMC8078718
doi:

Substances chimiques

Antibodies, Bacterial 0
Pneumococcal Vaccines 0
Vaccines, Conjugate 0

Banques de données

ClinicalTrials.gov
['NCT01485406']

Types de publication

Clinical Trial, Phase I Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1463-1469

Références

Expert Rev Vaccines. 2017 Jun;16(6):641-656
pubmed: 28425818
Expert Rev Vaccines. 2017 Feb;16(2):109-121
pubmed: 26954689
PLoS One. 2016 Dec 12;11(12):e0166736
pubmed: 27941979
Clin Diagn Lab Immunol. 2001 Mar;8(2):266-72
pubmed: 11238206
Lancet Glob Health. 2018 Jul;6(7):e744-e757
pubmed: 29903376
Vaccine. 2009 May 21;27(24):3213-22
pubmed: 19446194
PLoS One. 2017 May 9;12(5):e0177113
pubmed: 28486544
Vaccine. 2017 Aug 16;35(35 Pt B):4501-4509
pubmed: 28711387
Vaccine. 2019 Jan 3;37(1):176-186
pubmed: 30054160
Vaccine. 2010 Aug 2;28(34):5513-23
pubmed: 20600514
Vaccine. 2017 Sep 12;35(38):5186-5193
pubmed: 28797727
BMC Infect Dis. 2015 Oct 14;15:419
pubmed: 26468008
PLoS One. 2015 Mar 17;10(3):e0120290
pubmed: 25781031
J Infect Dis. 2007 Aug 15;196(4):537-40
pubmed: 17624838
Vaccine. 2017 Aug 16;35(35 Pt B):4603-4611
pubmed: 28729019
Clin Infect Dis. 2016 May 1;62 Suppl 2:S96-S105
pubmed: 27059362
Hum Vaccin Immunother. 2012 May;8(5):612-22
pubmed: 22634448
Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S109-18
pubmed: 19325447
Vaccine. 2014 Mar 14;32(13):1501-6
pubmed: 24486346
Lancet Respir Med. 2014 Jun;2(6):464-71
pubmed: 24726406
J Pediatric Infect Dis Soc. 2016 Sep;5(3):237-248
pubmed: 27125273
Lancet Infect Dis. 2018 Nov;18(11):1191-1210
pubmed: 30243584
Int J Pediatr Otorhinolaryngol. 2017 Sep;100:174-182
pubmed: 28802367
Clin Infect Dis. 2017 Nov 13;65(11):1780-1789
pubmed: 29020171
Clin Vaccine Immunol. 2010 Jan;17(1):134-42
pubmed: 19889940

Auteurs

Michael Horn (M)

Pediatric Office, Schönau Am Königssee, Germany.

Ulrich Behre (U)

Private Practice, Kehl, Germany.

Magali Traskine (M)

HPV, Hepatitis and Pneumococcal Vaccines, Clinical R&D, GSK, Wavre, Belgium.

Kurt Dobbelaere (K)

HPV, Hepatitis and Pneumococcal Vaccines, Clinical R&D, GSK, Wavre, Belgium.

Dorota Borys (D)

HPV, Hepatitis and Pneumococcal Vaccines, Clinical R&D, GSK, Wavre, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH